A role for the putative error-prone polymerase REV1 in DNA damage and antifungal drug resistance in Candida albicans
Michelle R. Agyare-Tabbi, Deeva UthayakumariD, Desiree FrancisiD, Laetitia MarociD, Chris Grant, Peter McQueeniD, Garret Westmacott, Hajer Shaker, Iwona Skulska, Isabelle Gagnon‐ArsenaultiD, Jonathan Boisvert, Christian R. LandryiD, Rebecca S. ShapiroiD
Abstract
Antimicrobial-induced DNA damage, and subsequent repair via upregulation of DNA repair factors, including error-prone translesion polymerases, can lead to the increased accumulation of mutations in the microbial genome, and ultimately increased risk of acquired mutations associated with antimicrobial resistance. While this phenotype is well described in bacterial species, it is less thoroughly investigated amongst microbial fungi. Here, we monitor DNA damage induced by antifungal agents in the fungal pathogen Candida albicans, and find that commonly used antifungal drugs are able to induce DNA damage, leading to the upregulation of transcripts encoding predicted error-prone polymerases and related factors. We focus on REV1, encoding a putative error-prone polymerase, and find that while deleting this gene in C. albicans leads to increased sensitivity to DNA damage, it also unexpectedly renders cells more likely to incur mutations and evolve resistance to antifungal agents. We further find that deletion of REV1 leads to a significant depletion in the uncharacterized protein Shm1, which itself plays a role in fungal mutagenesis. Together, this work lends new insight into previously uncharacterized factors with important roles in the DNA damage response, mutagenesis, and the evolution of antifungal drug resistance.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 6
- FWCI
- 0.69
- Field percentile
- top 36%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Reduced Cdc14 phosphatase activity impairs septation, hyphal differentiation and pathogenesis and causes echinocandin hypersensitivity in Candida albicans
Kedric L. Milholland, Ahmed AbdelKhalek, … Mark C. Hall·bioRxiv·Sep 29, 2022
- Inhibition of Ras1-MAPK pathways for hypha formation by novel drug candidates in Candida albicans
Y. K. Park, J. Shin, … J. Kim·bioRxiv·Jul 6, 2021
- Metabolic pathway competition sensitizes thioredoxin reductase-depleted Candida albicans to cell wall stress and antifungals
Wanjun Qi, Udita Roy, … Julia R. Köhler·bioRxiv·Dec 3, 2025
- The distinct biochemical property enables thymidylate kinase as a drug target and participates in pyrimidine drug sensitivity in Candida albicans
Chang-Yu Huang, Yee-Chun Chen, … Zee-Fen Chang·bioRxiv·Nov 9, 2018
- Multiple mechanisms impact fluconazole resistance of mutant Erg11 proteins in Candida glabrata
Bao Gia Vu, Scott Moye-Rowley·bioRxiv·Jun 23, 2021
- Ploidy determines the consequences of antifungal-induced mutagenesis in Candida albicans, a human fungal pathogen
Ognenka Avramovska, Meleah A. Hickman·G3 Genes Genomes GeneticsPeer-reviewed·Oct 5, 2019